| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 4th January 2021 | William E Kennard | 814 | Grant/award etc. | $46.08 | $37,509.12 |
| 4th January 2021 | Edward J Iii Kelly | 814 | Grant/award etc. | $46.08 | $37,509.12 |
| 4th January 2021 | Steven A Kandarian | 2,500 | Grant/award etc. | $0.00 | |
| 4th January 2021 | Robert Glenn Hubbard | 1,492 | Grant/award etc. | $46.08 | $68,751.36 |
| 17th December 2020 | Robert Glenn Hubbard | 407.71 | Exercise of derivative | $0.00 | |
| 17th December 2020 | Robert Glenn Hubbard | 653.3 | Exercise of derivative | $0.00 | |
| 17th December 2020 | Robert Glenn Hubbard | 407.71 | Sale back to the issuer | $14.89 | $6,070.80 |
| 17th December 2020 | Robert Glenn Hubbard | 591.83 | Exercise of derivative | $0.00 | |
| 17th December 2020 | Robert Glenn Hubbard | 639.4 | Sale back to the issuer | $8.39 | $5,364.57 |
| 17th December 2020 | Robert Glenn Hubbard | 639.4 | Exercise of derivative | $0.00 |
Met Life
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
MetLife, Inc. provides insurance and financial services to individual and institutional customers. The company operates through the following segments: U.S., Asia, Latin America, EMEA, MetLife Holdings and Corporate & Other. It offers life insurance, annuities, automobile and homeowner's insurance and retail banking services.
Ticker: MET
Sector: Financial Services
Industry: Insurance—Life
SEC Central Index Key (CIK): 1099219
Employees: 49000
Exchange: New York Stock Exchange
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Restructuring Charges of $0 for the period Apr 2020 to Jun 2020 in the context of Other expense
Restructuring Charges of $0 for the period Jan 2020 to Jun 2020 in the context of Other expense
Restructuring Charges of $14 M for the period Apr 2019 to Jun 2019 in the context of Other expense
Restructuring Charges of $21 M for the period Jan 2019 to Jun 2019 in the context of Other expense
Fundamentals
Cash at Carrying Value: $24 B (46%)
Assets: $768 B (0%)
Short-term Debt: $303 M (28%)
Liabilities: $692 B (2%)
Common Stock, Value, Issued: $12 M (0%)
Common Stock, Shares, Issued: $1 B (0%)
Retained Earnings (Accumulated Deficit): $37 B (10%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $19 B (0%)
Treasury Stock, Value: $132 Th (3%)
Treasury Stock, Shares: $3 B (4%)
Stockholders' Equity (Parent): $76 B (14%)
Liabilities and Equity: $768 B (3%)
Revenue: $324 M (-51%)
Sales and Marketing: $1 B (-51%)
General and Administrative Expenses: $191 M (-49%)
Provision for income taxes: $47 M (0%)
EPS (basic): $0.07 (0%)
EPS (diluted): $0.07 (0%)
News
The R.I.P. Portfolio's Q4 2020 Update
4th January 2021
MetLife: A Capital Return Story
28th December 2020
Zurich Insurance: MetLife P&C Acquisition Is A Good Deal All-Around
26th December 2020
Wall Street Breakfast: Prepare For A No-Deal Brexit
11th December 2020